A Patient with Corneal Epithelial Disorder That Developed after Administration of a Latanoprost Generic, but Not a Brand-Name Drug, Eye Drop

Background. We report a patient who developed corneal epithelial disorder repeatedly after changing the prescription from Xalatan eye drops (Pfizer Inc.) to Latanoprost eye drops (Kaken Pharmaceutical Co., Ltd.), both containing 0.005% latanoprost. Case Report. An 88-year-old male with glaucoma had...

Descripción completa

Detalles Bibliográficos
Autores principales: Takada, Yukihisa, Okada, Yuka, Fujita, Norihito, Saika, Shizuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467777/
https://www.ncbi.nlm.nih.gov/pubmed/23082262
http://dx.doi.org/10.1155/2012/536746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467777/
https://www.ncbi.nlm.nih.gov/pubmed/23082262
http://dx.doi.org/10.1155/2012/536746

Ejemplares similares